Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000156853 | SCV000206574 | benign | not specified | 2014-10-17 | criteria provided, single submitter | clinical testing | c.2241-10A>T in intron 11 of GPR98: This variant is not expected to have clinica l significance because it does not cause the splice site sequence to diverge fro m consensus. It has been identified in 5.1% (9/178) of Japanese chromosomes and 1.0% (2/194) of Han Chinese chromosomes by the 1000 Genomes Project (dbSNP rs150 996234). |
Gene |
RCV000710443 | SCV000717996 | benign | not provided | 2019-10-03 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000710443 | SCV000840661 | benign | not provided | 2018-03-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000710443 | SCV001047572 | benign | not provided | 2025-01-23 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001154173 | SCV001315508 | likely benign | Usher syndrome type 2C | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Fulgent Genetics, |
RCV002492605 | SCV002795992 | likely benign | Usher syndrome type 2C; Febrile seizures, familial, 4 | 2021-07-20 | criteria provided, single submitter | clinical testing |